|
|
|
Tuesday, July 21, 2015
|
|
|
|
|
8:00 am -
8:30 am
|
|
|
8:30 am -
11:45 am
|
Workshop A: Evaluate Services to Include When Designing and Implementing a Hub |
It is important to understand the value of different design elements before making the high investments necessary to develop and
maintain a Hub program. Explore the intricacies of varying elements that would ensure the program has the processes and capabilities
necessary to deliver the desired patient services while also capturing information that can contribute to the brand or corporate strategy.
- Evaluate the benefits and shortcomings of designing the Hub to support one product, a portfolio of products, or the overall organization as a whole
- Assess how the product profile and patient profile impact which services should be included
- Determine what data is valuable to the organization and the process and systems necessary to capture that data
- Identify the necessary internal departments that should be involved in the implementation and execution of Hub services
- Build an implementation timeline outlining required processes and timing in relation to the product’s milestone dates
|
|
|
Kristin Britton
Manager, Access Strategy
Biogen
|
|
|
Andrew Thorrens
Head, Reimbursement and Market Access
Actavis
|
|
|
| Note: Workshop A is NOT part of the live or archived webcast. |
|
|
8:30 am -
11:45 am
|
Workshop B: Identify the Ideal Network of Distribution for Specific Products |
The factors that influence the choice of which channels to contract with ultimately drive the decisions around a specialty product’s distribution strategy. Discuss the benefits and shortcomings of different types of distribution partners, and evaluate how those choices come together to make up the channel strategy. Explore factors that drive decisions around how open, contracted, limited, or exclusive the network should be — in terms of desire for control on balance to limiting access — as well as the typical attributes of a product that may lead to the decision to have a more open or closed network.
- Determine the value of the network by identifying what capabilities or services would help ensure product value
- Explore the approach to the distribution selection by examining the offerings and selecting partners based on access
- Determine the necessary services and capabilities offered by various partners such as patient support programs, patient or provider
education, market development strategies, patient retention, etc.
- Identify key metrics to ensure high quality services are delivered by the distribution partners
- Add quality measures to ensure checks and balances on needed services of distribution partners
- Discuss ways to measure the return on investment of the network selection and the needs of the product
|
|
|
Eric R. Toppy
Global Launch Leader, Invokana
Global Commercial Strategic Marketing
Johnson & Johnson
|
|
|
| Note: Workshop B is NOT part of the live or archived webcast. |
|
|
|
|
|
11:45 am -
1:00 pm
|
|
|
|
|
|
1:15 pm -
2:00 pm
|
Identify the Benefits Different Partners Bring to a Product’s Distribution Strategy |
Developing the optimal distribution network for specialty products requires an analysis of the key attributes channel partners can bring to
the table, including clinical service offerings, data capture capabilities and ownership, patient reach, ability to enhance patients’ speed to
therapy, and more. Assess the needs, demands, and optimal coordination for managing specialty distribution between the manufacturer, the
distributor, and the provider’s office, and how the distribution mix aligns with resources.
- Evaluate what goes into the network selection by the manufacturer and how the choice of network impacts patient access
- Discuss the benefits and shortcomings of different partners’ responsibilities, including handling benefits examinations, providing clinical
support, collecting and sharing data, etc.
- Leverage big data to identify ideal distribution strategies and reign in unnecessary costs
- Evaluate potential arrangements for distribution partners to share data
|
| Moderator: |
|
|
| Panelists: |
|
|
|
|
Peter K. Yi, MBA
Director, Patient Access and Channel Operations
Acadia Pharmaceuticals Inc.
|
|
|
|
|
2:00 pm -
2:45 pm
|
Aid the Patient Journey by Understanding the Needs of the Patient and Interaction with the Distribution Channel |
Concise care coordination and information exchange is critical to maintain patient relationships. Manufacturers must understand the patient needs, and
cater to their experience. By keeping this focus, manufacturers can develop ways to better the patient journey by optimizing coordination with channel
partners to improve the continuum of care, enhance speed to therapy, halt unfilled prescriptions, and ultimately achieve greater patient retention.
- Understand the patient journey to identify opportunities to improve the user experience
- Evaluate methods to engage patients through the channel by aligning with advocacy groups or nonprofit foundations
- Aggregate the appropriate and optimal level of data needed to track the patient and drive retention
|
|
|
Bradley Dickerson
Vice President, Patient Services
NPS, A Shire Company
|
|
|
John Liu, JD
Executive Director, Reimbursement and Market Access Strategy
Astellas Pharma US
|
|
|
|
|
2:45 pm -
3:15 pm
|
|
|
3:15 pm -
4:00 pm
|
Develop Distribution Strategies that Enhance Payer Relationships |
Selection of the distribution network has an impact on payer relationships. With changes in reimbursement and benefit design,
manufacturers must focus on payer engagement and support to streamline patient access through the distribution channel and patient
support services. Examine the effects on market access of specialty products by monitoring reimbursement and distribution.
- Ensure reimbursement by coordinating networks with payer needs
- Work together on evidence generation and disease pathways to determine appropriate use and maximize opportunities for inclusion in formulary
- Leverage the Hub to align distribution and reimbursement needs, ensuring benefits investigations, prior authorizations, denied or underpaid
claim assistance, reimbursement coverage, patient assistance programs, copay assistance, or product replacements as needed
- Establish standard operating procedures and metrics to ensure effective transfer and assess the return on investment
|
|
|
Michele A. Balint, RPh
Patient and Market Access Operations Director
Aegerion Pharmaceuticals
|
|
|
Lesly Charanza
Senior Director, Market Access and Business Relations, MS Franchise
Genzyme
|
|
|
|
|
4:00 pm -
4:45 pm
|
Grow U.S. Sales with a Plan for International Distribution and Hub Services |
When specialty products are approved in the U.S., patients in other countries may not have access to those drugs for years. Using an international
patient Hub, manufacturers can offer similar services as U.S.-based Hubs and coordinate shipment of products internationally. These programs help
patients get needed medication, help physicians around the world gain real-world clinical experience, and can be designed to credit U.S. sales.
- Align patient support service offerings globally
- Develop a distribution plan for helping patients and physicians who request product through the U.S.-based Hub
- Provide ongoing compliance and persistency, cost mitigation, reimbursement, and other services to patients in other countries
|
|
|
Douglas Bock
Principal
Vivaleas
|
|
|
|
|
4:45 pm -
5:30 pm
|
Roundtable Discussions: |
Bring your own agenda to make this part of the program one of the key take-home benefits of this conference. Roundtable discussions offer the opportunity to compare notes with your colleagues and to present your own successes and challenges on topics including:
Note: Roundtable Discussions are NOT part of the live or archived webcast.
|
Ensure Reimbursement and Access Solutions to Products at the Point of Launch |
| Facilitator: |
|
|
Enhance Speed to Therapy through Streamlined Coordination |
| Facilitator: |
|
|
Evaluate how REMS Affects Distribution Processes and Partners |
| Facilitator TBA |
|
|
|
5:30 pm -
6:30 pm
|
|
|
|
|
|
|
